GE Healthcare Introduces ÄKTA™ avant 150 Liquid Chromatography System for Accelerated Scale-up
Uppsala, Sweden – GE Healthcare, a unit of General Electric Company (NYSE: GE), announces the launch of ÄKTA™ avant 150, the second system in the new generation of ÄKTA liquid chromatography systems. ÄKTA avant 150 complements the ÄKTA avant 25 system to fully exploit the advantages of modern BioProcess media, enabling smooth development of scalable chromatographic processes for biopharmaceutical production.
With flow rates up to 150 ml/min, the ÄKTA avant 150 is designed for process development and scale up. The UNICORN™ 6.1 control software enables seamless method transfer between ÄKTA avant 25 and ÄKTA avant 150. UNICORN 6.1 also comes with integrated Design of Experiments (DoE) functionality that provides time and cost savings by capturing the information required for decision making in fewer experiments. ÄKTA avant includes several features for optimal operational security such as a cooled fraction collector and traceable column handling.
ÄKTA avant supports intelligent packing of AxiChrom™ columns for predictable scale up to production scale. The verified, preprogrammed packing methods available ensure optimally-packed beds and decrease operator dependence.
“The ultimate goal is to ensure smooth transition from product discovery to full scale production,” said Nigel Darby, Vice President, Bio-Technologies, GE Healthcare, “ÄKTA avant 150 has been designed for direct scalability using BioProcess media with dedicated column formats. From a production perspective this means cost-effective process development that avoids last-minute surprises.”
For more information please visit: www.gelifesciences.com/aktaavant
To view a video demonstration of AKTA avant, please visit: www.youtube.com/watch?v=JtNZllv_2Qs
About GE Healthcare:
GE Healthcare provides transformational medical technologies and services that are shaping a new age of patient care. Our broad expertise in medical imaging and information technologies, medical diagnostics, patient monitoring systems, drug discovery, biopharmaceutical manufacturing technologies, performance improvement and performance solutions services help our customers to deliver better care to more people around the world at a lower cost. In addition, we partner with healthcare leaders, striving to leverage the global policy change necessary to implement a successful shift to sustainable healthcare systems.
Our “healthymagination” vision for the future invites the world to join us on our journey as we continuously develop innovations focused on reducing costs, increasing access and improving quality around the world. Headquartered in the United Kingdom, GE Healthcare is a unit of General Electric Company (NYSE: GE). Worldwide, GE Healthcare employees are committed to serving healthcare professionals and their patients in more than 100 countries. For more information about GE Healthcare, visit our website at www.gehealthcare.com.